(Q21245617)

18 August 2022

4

Rajesh

Balkrishnan

Rajesh Balkrishnan

1 reference

18 August 2022

Monali J Bhosle

1

Monali J

Bhosle

1 reference

1030559616

18 August 2022

Amit Kulkarni

series ordinal

2

author given names

Amit

author last names

Kulkarni

1 reference

1030559616

Health and Quality of Life Outcomes

18 August 2022

language of work or name

English

0 references

publication date

2006

0 references

published in

0 references

volume

4

0 references

issue

1

0 references

page(s)

35

0 references

cites work

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Psychologic factors in psoriasis: consequences, mechanisms, and interventions.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Decision points for the initiation of systemic treatment for psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Quality of life issues in psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The impact of psoriasis on quality of life

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Psoriasis: current perspectives with an emphasis on treatment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Future psoriasis therapy.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The Salford Psoriasis Index: an holistic measure of psoriasis severity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Psoriasis causes as much disability as other major medical diseases

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

An Italian study on psoriasis and depression

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Effects of patient satisfaction with care on health-related quality of life: a prospective study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The effect of treatment on quality of life in psoriasis patients

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The direct cost of care for psoriasis and psoriatic arthritis in the United States

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The prevalence of psoriasis in the world

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The economic impact of psoriasis increases with psoriasis severity.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Psoriasis and sex: a study of moderately to severely affected patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

The effect of severe psoriasis on the quality of life of 369 patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501000

Suicidal ideation in psoriasis

29 November 2018

1 reference

12 December 2020

Skin disease and handicap: an analysis of the impact of skin conditions

1 reference

12 December 2020

Group therapy: a useful and supportive treatment for psoriasis patients

1 reference

12 December 2020

Current treatment options in psoriasis

1 reference

12 December 2020

Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis

1 reference

12 December 2020

Social coping strategies associated with quality of life decrements among psoriasis patients

1 reference

12 December 2020

The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis

1 reference

12 December 2020

Quantifying the harmful effect of psoriasis on health-related quality of life

1 reference

12 December 2020

1 reference

12 December 2020

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis

1 reference

12 December 2020

[Stigmatization and quality of life of patients with psoriasis and atopic dermatitis]

1 reference

12 December 2020

Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction

1 reference

12 December 2020

Determinants of quality of life in patients with psoriasis: A study from the US population

1 reference

12 December 2020

The negative impact of psoriasis on the workplace

1 reference

12 December 2020

Psychosocial consequences of rejection and stigma feelings in psoriasis patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7525-4-35

1 reference

1030559616

0 references

1 reference

1 reference

PubMed publication ID

16756666

1 reference